AOD9604 5mg (10 Vials / Kit)

What is AOD-9604?

AOD-9604 corresponds to the C-terminal 176-191 region of human growth hormone, with an added N-terminal tyrosine for stability, and was designed to isolate the lipid-regulating portion of the GH molecule from its growth-promoting domain.

This listing is AOD-9604 (10 vials × 5mg) from UWA Biotech (United States), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

In preclinical work, AOD-9604 appears to engage adipocyte lipolysis pathways in a manner similar to full-length GH, promoting breakdown of stored triglycerides and limiting new fat formation, while not activating the growth-hormone-receptor pathways linked to IGF-1 elevation.

Research status

The peptide has been examined mainly in rodent and cell-culture models of obesity and fat metabolism, along with early-stage human trials conducted over a decade ago that did not lead to regulatory approval. It has also drawn interest in cartilage and joint-repair research; overall evidence remains preclinical and limited compared with approved metabolic therapies.

Specifications

Compound

AOD-9604

Also known as

hGH Fragment 176-191, Anti-Obesity Drug 9604

Class

Modified growth-hormone fragment peptide

Form

Lyophilized (freeze-dried) powder

Per vial

5mg

Units per kit

10

Brand

UWA Biotech · United States

Handling & storage

Provided as a lyophilized powder; keep unopened vials frozen at -20 C away from light, and store reconstituted solution refrigerated for the duration specified in the research protocol.

Concentration check: adding 2 ml of bacteriostatic water to one 5mg vial gives 2.5 mg/ml. The Research Lab calculator in your dashboard works this out for any volume.

Questions

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.